First Clinical Results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma
β Scribed by Burger, I. A.; Zitzmann-Kolbe, S.; Pruim, J.; Friebe, M.; Graham, K.; Stephens, A.; Dinkelborg, L.; Kowal, K.; Schibli, R.; Luurtsema, G.; Maas, B.; Horn-Tutic, M.; Haerle, S. K.; Wiegers, J.; Schaefer, N. G.; Hany, T. F.; von Schulthess, G. K.
- Book ID
- 127121697
- Publisher
- The Society of Nuclear Medicine
- Year
- 2014
- Tongue
- English
- Weight
- 930 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0161-5505
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background. This study assesses the additional value of ^18^Fβfluoroβ2βdeoxyβDβglucose positron emission tomography/CT (^18^FβFDGβPET/CT) with respect to synchronous primaries in patients undergoing panendoscopy for staging of head and neck squamous cell carcinoma. ## Methods. In
## Abstract ## Background. We investigated the accuracy of performing cervical nodal evaluation with using integrated ^18^Fβfluoro deoxyglucose positron emission tomography (PET)/CT for squamous cell carcinoma (SCC) of the head and neck as compared with using PET and contrastβenhanced CT (CECT) al